We are live on ! Find out more
ACM

Asymmetry Capital Management Portfolio holdings

AUM $188M
1-Year Est. Return 44.72%
This Fund
S&P 500
This Quarter Est. Return
+33.69%
1 Year Est. Return
+44.72%
3 Year Est. Return
+299.95%
5 Year Est. Return
+628.83%
10 Year Est. Return
–
AUM
$66.1M
AUM Growth
+$21.2M
Cap. Flow
+$13.7M
Cap. Flow %
20.71%
Top 10 Hldgs %
79%
Holding
27
New
5
Increased
8
Reduced
4
Closed
10

Top Buys

Rank Stock Value
1
PTCT icon
PTC Therapeutics
PTCT
+$6.98M
2
ACOR
Acorda Therapeutics
ACOR
+$5.3M
3
XNPT
XENOPORT, INC.
XNPT
+$5.2M
4
UNH icon
UnitedHealth
UNH
+$4.17M
5
DGX icon
Quest Diagnostics
DGX
+$2.21M

Top Sells

Rank Stock Value
1
DVA icon
DaVita
DVA
+$4.07M
2
SYK icon
Stryker
SYK
+$2.61M
3
MDXG icon
MiMedx Group
MDXG
+$2.22M
4
ENDP
Endo International plc
ENDP
+$1.84M
5
BMY icon
Bristol-Myers Squibb
BMY
+$1.77M

Sector Composition

Rank Sector Weight
1 Healthcare 80.09%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
SGNT
26
DELISTED
SAGENT PHARMACEUTICALS INC COM STK (DE)
SGNT
– –
-92,213
Closed -$1.41M
EPRS
27
DELISTED
EPIRUS BIOPHARMACEUTICALS INC COM
EPRS
– –
-42,787
Closed -$189K
1
2

Similar funds

FAC
Forrestal Agricultural Corporation Princeton, New Jersey $183M AUM
SWM
Strategic Wealth Management Kirkland, Washington $202M AUM 9.35% 1-Year Est. Return
MC
MRJ Capital New York $173M AUM 31.99% 1-Year Est. Return
KM
Kylin Management New York $173M AUM 39.51% 1-Year Est. Return
TI
Truehand Inc Strafford, New Hampshire $171M AUM 25.9% 1-Year Est. Return
GC
Grace Capital Quincy, Massachusetts $168M AUM 21.6% 1-Year Est. Return
REMS
Real Estate Management Services $167M AUM 37.69% 1-Year Est. Return
NM
Nokota Management New York $165M AUM

Asymmetry Capital Management's Q4 2015 Portfolio in Review

As of Q4 2015, Asymmetry Capital Management held 27 positions worth $66.1M, up 47% from $44.9M the previous quarter. Its ten largest holdings account for 79% of the portfolio.

Asymmetry Capital Management deployed $13.7M of net new capital in Q4 2015, opening 5 new positions and adding to 8 existing holdings. Its largest new stake was PTC Therapeutics: 237,100 shares worth $7.68M.

By sector, the portfolio is most concentrated in Healthcare at 80% of assets, down from 85% a quarter earlier.

On the sell side, the largest reduction was Edwards Lifesciences, an estimated $617K trimmed.

  • Asymmetry Capital Management's largest Q4 2015 buy was PTC Therapeutics: 237,100 shares worth $7.68M.
  • Asymmetry Capital Management added most to XENOPORT, INC. in Q4 2015, an estimated $5.2M increase.
  • Asymmetry Capital Management's biggest Q4 2015 reduction was Edwards Lifesciences, cutting an estimated $617K.
  • Asymmetry Capital Management fully exited DaVita in Q4 2015, selling an estimated $4.07M.
  • Asymmetry Capital Management's ten largest holdings make up 79% of its $66.1M portfolio in Q4 2015.
  • Asymmetry Capital Management opened 5 new positions and closed 10 in Q4 2015.
  • Asymmetry Capital Management's portfolio value rose 47% quarter-over-quarter to $66.1M.

Based on Asymmetry Capital Management's 13F filing for Q4 2015, filed 3 Feb 2016.